We also used the “pathological stage plot” module of GEPIA2(Gene Expression Profiling Interactive Analysis, version 2) to analyze the correlation between KDM4B expression and the pathological stages of cancers and found robust KDM4B expression in ACC, BRCA, colon adenocarcinoma, OV, pancreatic adenocarcinoma, thyroid carcinoma (THCA), CESC, and UCEC (Figure 6D, p < 0.05) but not other cancers (Figure S2B). This evidence concerns the gene KDM4B and thyroid gland carcinoma.